Rama Padmanabhan - MergerLinks

Financial Data and Systems

MajorityAcquisitionPublicPrivate Equity

target

Gain Capital Holdings

bidder

Stonex Group

£133m

44 dealmakers

AcquisitionPrivateMajorityCross Border

target

Pvp Biologics

bidder

Takeda Pharmaceutical Company

£255m

12 dealmakers

PrivateMajorityAcquisitionReverse TakeoverMergerDomesticPrivate EquityDe-SPAC

target

Nuvation Bio

bidder

Panacea Acquisition Corp

£650m

34 dealmakers

MajorityPublicAcquisitionCross Border

target

Viela Bio

bidder

Horizon Therapeutics

£2,262m

42 dealmakers

PrivateAcquisitionMajorityDomesticPrivate Equity

target

ONCOCEUTICS

bidder

CHIMERIX

£57m

16 dealmakers

PrivateCross BorderMajorityAcquisition

target

Silicon Therapeutics

bidder

Roivant Sciences

£322m

22 dealmakers

DomesticMajorityPrivateAcquisition

target

Amplyx Pharmaceuticals

bidder

Pfizer

value n/a

29 dealmakers

Electronic Components and Equipment

MajorityCross BorderMergerPrivateDe-SPACAcquisitionReverse Takeover

target

Quanergy Systems

bidder

Citic Capital Acquisition

£792m

52 dealmakers

Indonesia

FinTech

De-SPACMajorityPrivate EquityAcquisitionPrivateCross BorderReverse Takeover

target

Kredivo Holdings (ex Finaccel)

bidder

Palantir Technologies

£1,798m

85 dealmakers

Private EquityMajorityAcquisitionPrivateDomestic

Data Centers and Hosting

target

CLOSINGCORP

bidder

Stone Point Capital

value n/a

34 dealmakers

Japan

Payments / Commerce

Cross BorderPrivateAcquisitionMajority

target

PAIDY

bidder

Paypal Holdings

£1,950m

77 dealmakers

MajorityVenture CapitalDomesticAcquisitionPrivate EquityPrivate

target

BIOTHERANOSTICS

bidder

Hologic

£168m

12 dealmakers

Customer Relationship Management

AcquisitionMajorityDomesticPrivatePrivate Equity

target

PRODEGE

bidder

Great Hill Partners

value n/a

18 dealmakers

PrivateAcquisitionMajorityDomestic

target

BIODISCOVERY

bidder

Bionano Genomics

£74m

22 dealmakers

MajorityAcquisitionDomesticPrivate

target

Lengo Therapeutics

bidder

Blueprint Medicines

£348m

57 dealmakers

MajorityDomesticPrivateAcquisitionPrivate Equity

target

POLLFISH

bidder

PRODEGE

value n/a

23 dealmakers

Private EquityPrivateAcquisitionDomesticMajority

Data Centers and Hosting

target

INTRICATELY

bidder

Hg Insights

value n/a

19 dealmakers

PrivateMajorityDomesticAcquisition

target

Bioniz Therapeutics

bidder

EQUILLIUM

£268m

18 dealmakers

MajorityAcquisitionPrivateDomestic

target

TEMBEXA

bidder

Emergent Biosolutions

£275m

23 dealmakers

MajorityDomesticAcquisitionPrivate

target

VIACYTE

bidder

Vertex Pharmaceuticals

£265m

42 dealmakers

Germany

Information / Data Services

PrivateAcquisitionCross BorderMajority

target

BITBURST

bidder

PRODEGE

value n/a

19 dealmakers

MajorityMergerAcquisitionPrivateDomestic

target

Silverback Therapeutics

bidder

Ars Pharmaceuticals

£120m

46 dealmakers

AcquisitionDomesticMajorityPublic

target

Metacrine

bidder

EQUILLIUM

£28m

13 dealmakers

Reverse TakeoverDe-SPACMergerDomesticAcquisitionPrivate

Health Care Services

target

Trisalus Life Sciences

bidder

Medtech Acquisition Corporation

£206m

37 dealmakers

Netherlands

Private EquityCross BorderAcquisitionMajorityPrivate

target

Neogene Therapeutics

bidder

Astrazeneca

£264m

60 dealmakers

PrivateDomesticMajorityAcquisition

target

Purigen Biosystems

bidder

Bionano Genomics

£52m

35 dealmakers

DomesticAcquisitionPublicMajority

target

Horizon Therapeutics

bidder

Amgen

£22,860m

87 dealmakers

MajorityAcquisitionCross BorderPublicPrivate Equity

target

Cincor Pharma

bidder

Astrazeneca

£1,487m

79 dealmakers

Private EquityAcquisitionDomesticMajorityDe-SPACPrivateMergerReverse Takeover

target

Nkgen Biotech

bidder

Graf Acquisition Corp

£127m

38 dealmakers

United Kingdom

PrivateMajorityCross BorderAcquisition

target

BROADBEAN

bidder

VERITONE

£41m

103 dealmakers

Canada

Cross BorderAcquisitionMajorityPublic

target

Chinook Therapeutics

bidder

Novartis

£2,781m

75 dealmakers

MajorityAcquisitionPrivateDomestic

target

Travere Therapeutics (bile Acid Product Portfolio)

bidder

Mirum Pharmaceuticals

£366m

32 dealmakers

AcquisitionDomesticPrivateMajority

target

Tentarix Biotherapeutics

bidder

Gilead Sciences

£52m

13 dealmakers

PrivateAcquisitionDomesticMajority

target

SITKA

bidder

ARISTAMD

value n/a

24 dealmakers

China

AcquisitionCross BorderMajorityPublic

target

Gracell Biotechnologies

bidder

Astrazeneca

£971m

34 dealmakers